Common radiopharmaceuticals used in CMH include Technetium-99m, Iodine-131, FDG, Gallium-68, Samarium-153, and Thallium-201. These are applied in the diagnosis and treatment of thyroid disorders, cancer, cardiac issues, infections, and bone diseases. Their radioactivity is short-lived and precisely controlled, ensuring patient safety during nuclear medicine procedures.